EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Sponsor: Boehringer Ingelheim
Oklahoma City, OK · +206 more sites
8 recruiting type 2 diabetes studies with a site in Oklahoma City, OK.
All trials in Oklahoma City, OK · All Type 2 Diabetes trials
Sponsor: Boehringer Ingelheim
Oklahoma City, OK · +206 more sites
Sponsor: AstraZeneca
Oklahoma City, OK · Tulsa, OK · +54 more sites
Sponsor: Ascletis Pharma (China) Co., Limited
Oklahoma City, OK · +83 more sites
Sponsor: Corxel Pharmaceuticals
Oklahoma City, OK · +33 more sites
Sponsor: AstraZeneca
Oklahoma City, OK · +63 more sites
Sponsor: Eli Lilly and Company
Oklahoma City, OK · +40 more sites
Sponsor: University of Oklahoma
Oklahoma City, OK
Sponsor: Sun Pharmaceutical Industries Limited
Oklahoma City, OK · +8 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.